Nevertheless, we demonstrated a significant improvement in transplant-free survival and a trend toward significance with the change in 6MWD.
← all excerpts
Antifibrotic therapy combined with pulmonary vasodilator therapy may improve survival in patients with pulmonary fibrosis and pulmonary hypertension: a retrospective cohort study.
1
—
—